The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a not-for-profit organization, dedicated to a close interaction between clinical scientists dealing with bone, joint and muscle disorder, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of Osteoporosis and Osteoarthritis within the comprehensive perspective of health resources utilization.

The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.

 


 

ATLAS OF OSTEOARTHRITIS

Recently published by Springer Healthcare in partnership with the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), the Atlas of Osteoarthritis - Second Edition is now FREE to download for the ESCEO Associate Members.

It includes an updated chapter on the treatment of osteoarthritis and a new chapter on SYSADOAs.

Click here to download the Atlas.

 


 

JOURNAL

Aging clinical and experimental research offers a multidisciplinary forum on the progressing field of gerontology and geriatrics. The areas covered by the journal include: biogerontology, neurosciences, epidemiology, clinical gerontology and geriatric assessment, social, economical and behavioral gerontology. “Aging clinical and experimental research” appears bimonthly and publishes review articles, original papers and case reports.

 

Discover the official journal of ESCEO on Springer.com and read the journal contents on Springerlink.com.
You can get the table of contents of every new issue published in Aging Clinical and Experimental Research. Sign up for the ToC Alert for this journal with your e-mail address. It’s easy and it’s free.

 


 

WCO-IOF-ESCEO Barcelona 2020

WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES

The members of the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) and the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) are thrilled to welcome you, from April 2 to April 5, 2020 in the beautiful city of Barcelona in Spain.

For this 20th Edition of the WCO-IOF-ESCEO Congress, they members of the Committee of Scientific Advisors of the IOF and the Scientific Advisory Board of ESCEO are developing a very exciting Congress’ scientific programme that will bring together the world’s best in the field of musculoskeletal health and disease.

We really hope to welcome you in Barcelona and that this Congress will move the field one step forward on all fronts; from new understanding of bone metabolism and pathology, to new strategies and options in prevention, diagnosis and treatment.

The city of Barcelona offers a most convenient and pleasant setting for international congresses. We hope that you will also take the opportunity to explore its many attractions!

The future edition of the WCO-IOF-ESCEO Congress will be held in 2020 in Barcelona (Spain). We are eagerly looking forward to counting you among our privileged participants for this future edition.

Kindest personal regards,

Jean-Yves Reginster,
President ESCEO

John A. Kanis,
Honorary IOF President

 


 

The Daily News of the WCO-IOF-ESCEO 2019 in Paris

Download here the first news

Download here the second news

 

 


 

The latest Abstract Book

1.416 abstracts were submitted for this 2019 edition of the WCO-IOF-ESCEO!

We invite you to discover the abstracts selected for the WCO-IOF-ESCEO by accessing the Abstract Book under this link.

 
"Why Patented Crystalline Glucosamine Sulfate (pCGS) is different from Other Glucosamines in the Treatment of Osteoarthritis (OA) and Should be Recommended as First Line Therapy"
In December 2015, the paper published by Olivier Bruyère, member of the Scientific Advisory Board of ESCEO, in Seminars in Arthritis and Rheumatism (2014) has benefited from a high visibility in the Asian press: a total of 160 media postings in Thailand, China, Russia and in international outlets with a potential audience of almost 80.000.000 visitors a day.
This is a huge opportunity for ESCEO and for our Osteoarthritis Treatment Algorithm to be seen and read all over the world.
 

Our 2020 congress in Barcelona, Spain

Our 2021 congress in London, United Kingdom